The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity
- PMID: 2153271
- DOI: 10.1212/wnl.40.1.1
The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity
Abstract
Thirty-six clinically diagnosed and pathologically confirmed Alzheimer's disease (AD) patients included 13 with cortical and subcortical Lewy bodies (LBs). The patients with LBs appeared to constitute a distinct neuropathologic and clinical subset of AD, the Lewy body variant (LBV). The LBV group showed gross pallor of the substantia nigra, greater neuron loss in the locus ceruleus, substantia nigra, and substantia innominata, lower neocortical ChAT levels, and fewer midfrontal tangles than did the pure AD group, along with a high incidence of medial temporal lobe spongiform vacuolization. Analysis of neuropsychological tests from 9 LBV subjects and 9 AD patients matched for age and degree of dementia revealed greater deficits in attention, fluency, and visuospatial processing in the LBV group. Similar comparisons of neurologic examinations showed a significant increase in masked facies; in addition there was an increase in essential tremor, bradykinesia, mild neck rigidity, and slowing of rapid alternating movements in the LBV group. Extremity rigidity, flexed posture, resting tremor, or other classic parkinsonian features were not characteristic of the LBV patient. In some cases, it may be possible to diagnose LBV premortem on the basis of the clinical and neuropsychological features.
Comment in
-
Lewy body variant.Neurology. 1990 Jul;40(7):1147-50. doi: 10.1212/wnl.40.7.1147. Neurology. 1990. PMID: 2162502 No abstract available.
Similar articles
-
Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease.J Neuropathol Exp Neurol. 1996 Jan;55(1):44-52. doi: 10.1097/00005072-199601000-00005. J Neuropathol Exp Neurol. 1996. PMID: 8558171
-
Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies.Neurology. 1993 Oct;43(10):1927-34. doi: 10.1212/wnl.43.10.1927. Neurology. 1993. PMID: 8105420
-
Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX.Neurology. 1999 Jun 10;52(9):1839-44. doi: 10.1212/wnl.52.9.1839. Neurology. 1999. PMID: 10371532
-
Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease.Brain Cogn. 1995 Aug;28(3):259-65. doi: 10.1006/brcg.1995.1256. Brain Cogn. 1995. PMID: 8546853 Review.
-
How to diagnose dementia with Lewy bodies: state of the art.Mov Disord. 2005 Aug;20 Suppl 12:S11-20. doi: 10.1002/mds.20535. Mov Disord. 2005. PMID: 16092075 Review.
Cited by
-
Cerebrospinal fluid biomarkers in Parkinson disease.Nat Rev Neurol. 2013 Mar;9(3):131-40. doi: 10.1038/nrneurol.2013.10. Epub 2013 Feb 19. Nat Rev Neurol. 2013. PMID: 23419373 Review.
-
Dementia with Lewy bodies - from scientific knowledge to clinical insights.Nat Rev Neurol. 2019 Feb;15(2):103-112. doi: 10.1038/s41582-018-0107-7. Nat Rev Neurol. 2019. PMID: 30559465 Review.
-
How Many Alzheimer-Perusini's Atypical Forms Do We Still Have to Discover?Biomedicines. 2023 Jul 19;11(7):2035. doi: 10.3390/biomedicines11072035. Biomedicines. 2023. PMID: 37509674 Free PMC article. Review.
-
α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox.Cell Biosci. 2021 Nov 19;11(1):196. doi: 10.1186/s13578-021-00709-y. Cell Biosci. 2021. PMID: 34798911 Free PMC article. Review.
-
Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5.Am J Pathol. 1995 Nov;147(5):1465-76. Am J Pathol. 1995. PMID: 7485409 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases